Act Capital Management, LLC Affimed N.V. Transaction History

Act Capital Management, LLC

$72.5 Million
Q3 2022

A detailed history of Act Capital Management, LLC transactions in Affimed N.V. stock. As of the latest transaction made, Act Capital Management, LLC holds 308,800 shares of AFMD stock, worth $1.13 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares

308,800

Previous 308,800 -0.0%

Holding current value

$1.13 Million

Previous $855,000 25.61%

% of portfolio

0.88%

Previous 1.2%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	BUY	$5.37 - $7.07 $147,675 - $194,425	27,500 Added 9.78%	308,800 $1.71 Million
Q3 2021 Nov 16, 2021	SELL	$5.54 - $7.51 $34,902 - $47,313	-6,300 Reduced 2.19%	281,300 $1.74 Million
Q2 2021 Aug 16, 2021	BUY	$7.78 - $11.4 $2.24 Million - $3.28 Million	287,600 New	287,600 $2.45 Million

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $545M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.

Account

Act Capital Management, LLC Affimed N.V. Transaction History